HCR — Health Issues
Rare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Rare disease drug development
Lobbyists: RACHEL SHER; HEIDE BAJNRAUH; mrs KENDALL BYRUM HUSSEY
6ea7ea12-56c0-4192-9413-98f99d4a9647Q1 — 1st Quarter - ReportLaw firm
Biopharmaceutical Company
HCR — Health IssuesRare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Rare disease drug development
Lobbyists: RACHEL SHER; HEIDE BAJNRAUH; mrs KENDALL BYRUM HUSSEY
pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.
Estimated value: $180/mo per user — but we made it free.